CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Exercise or conversion President & CEO acquired 124,667 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,936 shares (to pay taxes)
- 4 Exercise or conversion President & CEO acquired 40,000 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 45,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 4,168 shares (to pay taxes)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.96 ($9,600)
- 4 Open-market buy President & CEO bought 98,000 shares at $1.06 ($104,027)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President & CEO acquired 137,174 shares (option exercise)
Page 12 of 23 · 459 filings